Your browser doesn't support javascript.
loading
Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo.
Zoeller, Jason J; Bronson, Roderick T; Selfors, Laura M; Mills, Gordon B; Brugge, Joan S.
Affiliation
  • Zoeller JJ; Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, 02115 MA USA.
  • Bronson RT; Rodent Histopathology Core, Harvard Medical School, Boston, MA USA.
  • Selfors LM; Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, 02115 MA USA.
  • Mills GB; Systems Biology, UT MD Anderson Cancer Center, Houston, TX USA.
  • Brugge JS; Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, 02115 MA USA.
NPJ Breast Cancer ; 3: 18, 2017.
Article in En | MEDLINE | ID: mdl-28649658
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: NPJ Breast Cancer Year: 2017 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: NPJ Breast Cancer Year: 2017 Document type: Article Country of publication: